YEPELLAV Trademark

Trademark Overview

On Monday, March 9, 2020, a trademark application was filed for YEPELLAV with the United States Patent and Trademark Office. The USPTO has given the YEPELLAV trademark a serial number of 88826491. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 7, 2023. This trademark is owned by Glaxo Group Limited. The YEPELLAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
yepellav

General Information

Serial Number88826491
Word MarkYEPELLAV
Filing DateMonday, March 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, August 7, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 7, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2022SOU EXTENSION 4 GRANTED
Friday, September 9, 2022SOU EXTENSION 4 FILED
Friday, September 9, 2022TEAS EXTENSION RECEIVED
Wednesday, June 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022SOU EXTENSION 3 GRANTED
Monday, June 27, 2022SOU EXTENSION 3 FILED
Monday, June 27, 2022TEAS EXTENSION RECEIVED
Friday, December 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 23, 2021SOU EXTENSION 2 GRANTED
Monday, December 13, 2021SOU EXTENSION 2 FILED
Thursday, December 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 13, 2021TEAS EXTENSION RECEIVED
Friday, June 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 23, 2021SOU EXTENSION 1 GRANTED
Wednesday, June 23, 2021SOU EXTENSION 1 FILED
Wednesday, June 23, 2021TEAS EXTENSION RECEIVED
Tuesday, January 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION WRITTEN
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Friday, March 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 12, 2020NEW APPLICATION ENTERED

Related Keywords

yepellav pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological